<?xml version="1.0" encoding="UTF-8"?>
<p>Importantly, multivariate analysis of clinical history, NP swab positivity, and serology results suggests that donors who were hospitalized (suggesting more severe COVID‐19 disease) may provide more potent convalescent plasma, based on anti‐spike antibody reactivity as a measure of antiviral potency.
 <xref rid="trf16015-bib-0018" ref-type="ref">
  <sup>18</sup>
 </xref> However, this study is limited in the number of individuals enrolled and the enrichment for individuals who had mild to moderate COVID‐19, which is to be expected in a CP donor population during the early weeks of the epidemic. Further studies are needed to ensure that these findings hold true in larger cohorts and for longer follow‐up intervals.
</p>
